Quarterly report pursuant to Section 13 or 15(d)

Incentive and Non-Statutory Stock Option Plan (Tables)

v3.19.1
Incentive and Non-Statutory Stock Option Plan (Tables)
9 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Components of Common Stock Purchase Options

Common stock purchase options consisted of the following:

 

OPTIONS:

 

    # of shares     Weighted
Average
Exercise Price
    Weighted
Average
Remaining
Contractual
Life (in years)
    Aggregated
Intrinsic Value
 
                         
Outstanding and exercisable, June 30, 2018     53,462     $ 6.50       0.61     $        -  
Granted     -       -                  
Exercised     (13,076 )   $ 6.50                  
Expired / Cancelled     -       -                  
Outstanding and exercisable, March 31, 2019     40,386     $ 6.50       0.85     $ -  

Schedule of Stock Options and Warrants Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable at March 31, 2019.

 

Exercise Price     Number
Outstanding
and
Exercisable
    Weighted
Average
Remaining
Contractual
Life
    Weighted
Average
Exercise
Price
 
OPTIONS:                          
                           
$6.50       40,386       0.85     $ 6.50  
Totals       40,386       0.85     $ 6.50  

Schedule of Fair Value of Options Granted Assumptions

The fair market value was calculated using the Black-Scholes option pricing model with the following assumptions:

 

    March 31, 2019  
Risk-free interest rate     2.56 %
Expected life     1 year  
Expected volatility     45 %
Expected dividend     0 %

Summary of Unvested Stock Grants Awarded as Compensation

The following table summarizes stock grants awarded as compensation:

 

    # of shares     Weighted
Average Grant
Date Fair Value ($)
 
             
Unvested, June 30, 2018     155,648     $ 6.07  
Granted     112,276     $ 5.73  
Vested     (157,511 )   $ 6.05  
Unvested, March 31, 2019     110,413     $ 5.88